Clinical Trials List
Protocol NumberC3891001
Completed
2021-12-04 - 2024-09-30
Phase I
Recruiting3
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Pin Su 無
- 姜乃榕 無
- Jui-Hung Tsai 無
- Wu-Chou Su 無
- 劉奕廷 無
- Chia-Jui Yen 無
- Nai-Jung Chiang 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ling-Wei Wang 無
- Sheng-Yu Chen Division of Hematology & Oncology
- Mu-Hsin Chang 無
- Tien-Hua Chen 無
- 陳盛裕 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
50 participants
